Christopher P. Leamon

Vice President of Research, ENDOCYTE INC.

Companies

Fusion PharmaceuticalsChief Scientific Officer Nov 2, 2021 to Jun 4, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Fusion Pharmaceuticals FUSN0 shares²Jun 4, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 4, 2024Returned to company 11,957 shares of Fusion Pharmaceuticals²
Aug 31, 2023Granted 11,957 shares of Fusion Pharmaceuticals³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARFusion Pharmaceuticals, Chief Scientific Officer
2
SEC EDGARFusion Pharmaceuticals shares after the filing of Jun 4, 2024
3
SEC EDGARForm 4 filed Jan 5, 2024